Glucagon-like Peptide-1 Receptor Agonists - Diabetes Medication

Glucagon-like Peptide-1 Receptor Agonists are a class of medications used to manage blood sugar levels in individuals with type 2 diabetes.

Glucagon-like Peptide-1 Receptor Agonists FAQ

Image credit: youtube.com

What are glucagon-like peptide-1 agonists?

Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity. Examples of drugs in this class include exenatide, lixisenatide, liraglutide, albiglutide, dulaglutide, and semaglutide.

What are GLP-1 agonists?

GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonists are most often injectable medications, meaning you inject a liquid medication with a needle and syringe.

Are glucagon-like peptide 1 and GLP-1 receptor agonists a cardiovascular complication?

Possible cardiovascular actions of glucagon-like peptide 1 (GLP-1) and GLP-1 receptor agonists (GLP-1RAs). Diabetic kidney disease is a complication of diabetes that leads to increased mortality ( 40 ). Most GLP-1RA CVOTs incorporated secondary exploratory renal endpoints.

Can a GLP-1 agonist help with Type 2 diabetes?

If you become pregnant or are thinking of becoming pregnant. A note from Cleveland Clinic There’s no “best” way to manage Type 2 diabetes or obesity. Every person is unique and so is each treatment plan. But GLP-1 agonists may help. Talk to your healthcare provider to see if a GLP-1 agonist is right for you. They’re available to help.

What are glucagon-like peptide-1 receptor agonists?

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 that is released by the gut after eating.